SEC Form 4 · accession 0001871615-26-000014
Guardant Health, Inc. · GH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chris Freeman
Officer — Chief Commercial Officer
Period of report
Jul 1, 2026
Accepted (ET)
Jul 2, 2026 · 6:11 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001576280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2026 | M | 1,928 | $0.00 | A | 63,029 | D | |
| Common Stock | Jul 1, 2026 | M | 1,667 | $0.00 | A | 64,696 | D | |
| Common Stock | Jul 1, 2026 | M | 2,526 | $0.00 | A | 67,222 | D | |
| Common Stock | Jul 1, 2026 | M | 1,293 | $0.00 | A | 68,515 | D | |
| Common StockF1 | Jul 1, 2026 | F | 3,141 | $170.77 | D | 65,374 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | $0.00 | Jul 1, 2026 | M | 1,928 | D | — | — | Common Stock | 1,928 | 1,929 | D |
| Restricted Stock UnitsF4,F3 | $0.00 | Jul 1, 2026 | M | 1,667 | D | — | — | Common Stock | 1,667 | 1,668 | D |
| Restricted Stock UnitsF5,F3 | $0.00 | Jul 1, 2026 | M | 2,526 | D | — | — | Common Stock | 2,526 | 12,632 | D |
| Restricted Stock UnitsF6,F3 | $0.00 | Jul 1, 2026 | M | 1,293 | D | — | — | Common Stock | 1,293 | 9,046 | D |
Explanation of responses
- F1These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
- F3Not applicable for Restricted Stock Units.
- F4This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F6This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.